Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-neovascular Age-related Macular Degeneration”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Large-scale testing (Phase 3)Study completedNCT01782989
What this trial is testing

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Who this might be right for
Geographic Atrophy
Paul Yates, MD, PhD 286
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Not applicableStudy completedNCT02569892
What this trial is testing

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

Who this might be right for
Macular DegenerationRetinal Drusen
Stanford University 19
Not applicableStudy completedNCT04632056
What this trial is testing

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 329
Not applicableStudy completedNCT04169802
What this trial is testing

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Who this might be right for
Age Related Macular Degeneration
Kubota Vision Inc. 25
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Not applicableStudy completedNCT01204541
What this trial is testing

A Single-Center Pilot Study to Assess Macular Function

Who this might be right for
Macular Degeneration
ORA, Inc. 24
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Large-scale testing (Phase 3)Study completedNCT05587062
What this trial is testing

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Cinnagen 168
Not applicableEnrolling By InvitationNCT07660640
What this trial is testing

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

Who this might be right for
Age-Related Macular Degeneration (AMD)Non-Neovascular Age-Related Macular Degeneration
Perceive Biotherapeutics, Inc. 88
Not applicableLooking for participantsNCT07446582
What this trial is testing

Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection

Who this might be right for
Age-Related (Dry) Macular Degeneration
AI-Spectral 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT00935883
What this trial is testing

Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Philip J. Rosenfeld, MD, PhD 60
Not applicableStudy completedNCT01404845
What this trial is testing

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Who this might be right for
Exudative Age-related Macular Degeneration
Affordance 200
Next Page